Nasdaq Reports Second Quarter 2026 Results; $1.5 Billion in Net Revenue and Historic Milestones Reflect Broad-Based Momentum

Nasdaq reported Q2 2026 net revenue of $1.5B (+15% YoY) and GAAP diluted EPS of $0.89 (+14% YoY), with non-GAAP diluted EPS rising 25% to $1.07. Index ETP AUM topped $1.0T for the first time (end-period $1.114T) and generated $51B of net inflows in the quarter ($109B over the trailing 12 months), while Solutions revenue grew 17% (+$1.2B). The company returned $174M via dividends and $356M via share repurchases and updated 2026 non-GAAP operating expense guidance to $2.53B–$2.57B, signaling strong momentum and durable cash generation.

Analysis

Nasdaq is increasingly a recurring-revenue compounder wearing an exchange wrapper. The key signal is not the beat itself, but that index, data, and fintech are now large enough to offset the natural lumpiness of listings and trading, which should keep the market willing to pay up if organic ARR stays in the low-teens into 2027. The one caveat is that part of the headline growth is flattered by an index contract effect, so investors should not extrapolate the current growth rate linearly.

The second-order winner set extends beyond NDAQ. Banks, brokers, and asset managers with rising compliance and workflow spend should continue consolidating toward integrated platforms, which is favorable for larger vendors with multiple cross-sell entry points and unfavorable for niche reg-tech names that lack distribution. For competitors, the more important implication is mix: if the market starts treating exchange names as software-like recurring businesses, the relative valuation gap should widen between NDAQ and more transaction-heavy peers.

Near term, the stock should trade on estimate revisions and buyback support, but the catalyst path is 1-3 months, not days: Q3 listing momentum, ETF inflow durability, and cross-sell conversion will matter more than the quarter-end print. The thesis breaks if organic ARR slips back below 10%, if index inflows normalize sharply, or if management has to re-accelerate spending to defend growth. That is the right watchlist because the current move is only justified if recurring growth proves durable rather than event-driven.

Key Decisions for Investors

• Go long NDAQ on any 2-4% post-earnings fade; hold for 1-3 months into the next catalyst set. Risk/reward favors upside if the Street re-rates recurring revenue quality, with downside capped by ongoing buybacks.
• Pair trade: long NDAQ / short ICE for 3-6 months. NDAQ has the cleaner mix shift toward recurring software-like revenue and stronger capital return support; ICE is still more exposed to cyclical market activity and rate-sensitive volumes.
• If implied volatility is reasonable after the print, buy a 6-12 month NDAQ call spread rather than chasing spot. This captures re-rating potential if organic ARR remains low-teens while defining risk if listings or index flows cool.
• Set a downside alert on NDAQ if organic ARR guidance or commentary implies sub-10% growth, or if two consecutive quarters show material slowdown in index net inflows. That would be the first credible signal the multiple should compress.